Literature DB >> 21036827

Association between the pfmdr1 gene and in vitro artemether and lumefantrine sensitivity in Thai isolates of Plasmodium falciparum.

Mathirut Mungthin1, Rommanee Khositnithikul, Naruemon Sitthichot, Nantana Suwandittakul, Veerachai Wattanaveeradej, Stephen A Ward, Kesara Na-Bangchang.   

Abstract

We evaluated the influence of pfmdr1 mutations and copy number on in vitro artemether and lumefantrine sensitivity in 101 laboratory and adapted Thai isolates of Plasmodium falciparum. Approximately one-fourth of these isolates exhibited reduced lumefantrine susceptibility. We found that both mutations and amplification of the pfmdr1 gene influenced in vitro artemether and lumefantrine sensitivity. Using multivariate analysis, 184F or 1042N alleles and a copy number of ≥ 4 were identified as the independent markers for decreased lumefantrine susceptibility. Separate analysis also indicated that parasites from different geographical areas were influenced by different genetic markers.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21036827      PMCID: PMC2963959          DOI: 10.4269/ajtmh.2010.10-0339

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  30 in total

1.  Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study.

Authors:  F Nosten; M van Vugt; R Price; C Luxemburger; K L Thway; A Brockman; R McGready; F ter Kuile; S Looareesuwan; N J White
Journal:  Lancet       Date:  2000-07-22       Impact factor: 79.321

2.  Role of pfmdr1 amplification and expression in induction of resistance to artemisinin derivatives in Plasmodium falciparum.

Authors:  Marina Chavchich; Lucia Gerena; Jennifer Peters; Nanhua Chen; Qin Cheng; Dennis E Kyle
Journal:  Antimicrob Agents Chemother       Date:  2010-03-29       Impact factor: 5.191

3.  Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum.

Authors:  M T Duraisingh; C Roper; D Walliker; D C Warhurst
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

4.  Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.

Authors:  Elizabeth A Ashley; Srivicha Krudsood; Lucy Phaiphun; Siripan Srivilairit; Rose McGready; Wattana Leowattana; Robert Hutagalung; Polrat Wilairatana; Alan Brockman; Sornchai Looareesuwan; Francois Nosten; Nicholas J White
Journal:  J Infect Dis       Date:  2004-10-18       Impact factor: 5.226

Review 5.  Epidemiology of drug-resistant malaria.

Authors:  Chansuda Wongsrichanalai; Amy L Pickard; Walther H Wernsdorfer; Steven R Meshnick
Journal:  Lancet Infect Dis       Date:  2002-04       Impact factor: 25.071

6.  Human malaria parasites in continuous culture.

Authors:  W Trager; J B Jensen
Journal:  Science       Date:  1976-08-20       Impact factor: 47.728

7.  Resistance to antimalarials in Southeast Asia and genetic polymorphisms in pfmdr1.

Authors:  Amy L Pickard; Chansuda Wongsrichanalai; Anne Purfield; Deborah Kamwendo; Kathryn Emery; Christy Zalewski; Fumihiko Kawamoto; R Scott Miller; Steven R Meshnick
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

8.  Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number.

Authors:  Ric N Price; Anne-Catrin Uhlemann; Alan Brockman; Rose McGready; Elizabeth Ashley; Lucy Phaipun; Rina Patel; Kenneth Laing; Sornchai Looareesuwan; Nicholas J White; François Nosten; Sanjeev Krishna
Journal:  Lancet       Date:  2004 Jul 31-Aug 6       Impact factor: 79.321

9.  Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique.

Authors:  R E Desjardins; C J Canfield; J D Haynes; J D Chulay
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

10.  The pfmdr1 gene is associated with a multidrug-resistant phenotype in Plasmodium falciparum from the western border of Thailand.

Authors:  R N Price; C Cassar; A Brockman; M Duraisingh; M van Vugt; N J White; F Nosten; S Krishna
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

View more
  31 in total

1.  Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.

Authors:  Jing Yuan; Ken Chih-Chien Cheng; Ronald L Johnson; Ruili Huang; Sittiporn Pattaradilokrat; Anna Liu; Rajarshi Guha; David A Fidock; James Inglese; Thomas E Wellems; Christopher P Austin; Xin-zhuan Su
Journal:  Science       Date:  2011-08-05       Impact factor: 47.728

2.  Influence of the pfmdr1 Gene on In Vitro Sensitivities of Piperaquine in Thai Isolates of Plasmodium falciparum.

Authors:  Mathirut Mungthin; Ekularn Watanatanasup; Naruemon Sitthichot; Nantana Suwandittakul; Rommanee Khositnithikul; Stephen A Ward
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

3.  Role of Pfmdr1 in in vitro Plasmodium falciparum susceptibility to chloroquine, quinine, monodesethylamodiaquine, mefloquine, lumefantrine, and dihydroartemisinin.

Authors:  Nathalie Wurtz; Bécaye Fall; Aurélie Pascual; Mansour Fall; Eric Baret; Cheikhou Camara; Aminata Nakoulima; Bakary Diatta; Khadidiatou Ba Fall; Pape Saliou Mbaye; Yaya Diémé; Raymond Bercion; Boubacar Wade; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2014-09-08       Impact factor: 5.191

4.  CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.

Authors:  Caroline L Ng; Giulia Siciliano; Marcus C S Lee; Mariana J de Almeida; Victoria C Corey; Selina E Bopp; Lucia Bertuccini; Sergio Wittlin; Rachel G Kasdin; Amélie Le Bihan; Martine Clozel; Elizabeth A Winzeler; Pietro Alano; David A Fidock
Journal:  Mol Microbiol       Date:  2016-05-07       Impact factor: 3.501

5.  Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal.

Authors:  Nathalie Wurtz; Bécaye Fall; Aurélie Pascual; Silmane Diawara; Kowry Sow; Eric Baret; Bakary Diatta; Khadidiatou B Fall; Pape S Mbaye; Fatou Fall; Yaya Diémé; Christophe Rogier; Raymond Bercion; Sébastien Briolant; Boubacar Wade; Bruno Pradines
Journal:  Malar J       Date:  2012-06-13       Impact factor: 2.979

6.  Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study.

Authors:  Charles H Vaughan-Williams; Jaishree Raman; Eric Raswiswi; Etienne Immelman; Holger Reichel; Kelly Gate; Steve Knight
Journal:  Malar J       Date:  2012-12-28       Impact factor: 2.979

7.  Five years of antimalarial resistance marker surveillance in Gaza Province, Mozambique, following artemisinin-based combination therapy roll out.

Authors:  Jaishree Raman; Katya Mauff; Pedro Muianga; Abdul Mussa; Rajendra Maharaj; Karen I Barnes
Journal:  PLoS One       Date:  2011-10-14       Impact factor: 3.240

8.  Balanced impacts of fitness and drug pressure on the evolution of PfMDR1 polymorphisms in Plasmodium falciparum.

Authors:  Marvin Duvalsaint; Melissa D Conrad; Stephen Tukwasibwe; Patrick K Tumwebaze; Jennifer Legac; Roland A Cooper; Philip J Rosenthal
Journal:  Malar J       Date:  2021-06-30       Impact factor: 2.979

9.  Selection of pfcrt K76 and pfmdr1 N86 Coding Alleles after Uncomplicated Malaria Treatment by Artemether-Lumefantrine in Mali.

Authors:  Hamma Maiga; Anastasia Grivoyannis; Issaka Sagara; Karim Traore; Oumar B Traore; Youssouf Tolo; Aliou Traore; Amadou Bamadio; Zoumana I Traore; Kassim Sanogo; Ogobara K Doumbo; Christopher V Plowe; Abdoulaye A Djimde
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

10.  In vitro antimalarial susceptibility and molecular markers of drug resistance in Franceville, Gabon.

Authors:  Rafika Zatra; Jean Bernard Lekana-douki; Faustin Lekoulou; Ulrick Bisvigou; Edgard Brice Ngoungou; Fousseyni S Toure Ndouo
Journal:  BMC Infect Dis       Date:  2012-11-15       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.